The soluble mIL-15/IL-15Rα complex is bioactive, as demonstrated by its ability to stimulate enriched murine splenic NK cells to survive and proliferate in culture as well as reduce the viability of syngeneic glioma cells. The gene discussed is IL15RA; the disease is glioma.